Effects of Behavioral, Clinical, and Policy Interventions in Reducing Human Exposure to Bisphenols and Phthalates: A Scoping Review

Comprehensive analysis of transplacental transfer of environmental pollutants detected in paired maternal and cord serums

Prenatal exposure to hazardous environmental pollutants is a critical global concern due to their confirmed presence in umbilical cord blood, indicating the ability of pollutants to cross the placental barrier and expose the fetus to harmful compounds. However, the transplacental transfer efficiencies (TTEs) of many pollutants remain underexplored. Herein, we developed a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to quantitatively analyze 91 environmental pollutants, including 13 bisphenols (BPs), 18 organophosphorus flame retardants (OPFRs), 7 brominated and other flame retardants (BFRs), 34 phthalates (PAEs), and 19 per- and polyfluoroalkyl substances (PFASs), in paired maternal and cord serums. 38 pollutants were detected in serums, including 5 BPs, 13 OPFRs, 2 BFRs, 4 PAEs, and 14 PFASs. Among the detected pollutants, bisphenol A (BPA) exists in the highest concentration (GM: 10.92 ng/mL in maternal serums and 12.66 ng/mL in cord serums), followed by tris(1,3-dichloro-2-propyl) phosphate (TDCIPP), perfluorooctanoic acid (PFOA), and 4,4'-(1,3-phenylenediisopropylidene) bisphenol (BPM). The exposure concentrations of the same type of pollutants were highly correlated between maternal and cord serums. Perfluorohexanoic acid (PFHxA) had the highest TTE value (5.526), while perfluorooctane sulfonic acid (PFOS) had the lowest (0.206). TTEs of PFOS and perfluorononanoic acid (PFNA) were higher for female newborns, whereas TTEs of perfluorohexadecanoic acid (PFHxDA) and perfluorodecane sulfonic acid (PFDS) were higher for male newborns. Moreover, the expression levels of the transplacental transporters ABCA1, ABCC2, ABCC3, ABCC4, ABCG1, SLCO3A1, and SLC22A3 were associated with the transplacental transfer of triphenyl phosphate (TPHP), TDCIPP, di-n-propyl phthalate (DPRP), perfluoroundecanoic acid (PFUnDA), perfluorotridecanoic acid (PFTrDA), and PFOS. Further research is essential to unveil the mechanisms involved in the transplacental transfer of environmental pollutants, ultimately boosting our comprehension of their impact on fetal health and birth outcomes.

2,4-Bisphenol S triggers physiological changes, oxidative stress and lipidome alterations in Gram-positive Enterococcus faecalis at environmental concentrations

2,4-bisphenol S (2,4-BPS) was an emerging BPS analogue as color developers, widely found in the environment. Fish toxicities, cytotoxicity and antiestrogenic effects of 2,4-BPS have been documented at mg L-1, while the toxicity of 2,4-BPS at environmental concentrations (from ng L-1 to μg L-1) were scarce. Bacteria are identified as important components of the ecosystem, while little is known regarding the ecotoxicity of 2,4-BPS on bacteria. Enterococcus faecalis, a good indicator of faecal contamination and anthropogenic pollution, was exposed to 0.5-50 nmol L-1 2,4-BPS. 2,4-BPS resulted in significantly decreased growth but notably increased membrane permeability in E. faecalis compared with the control. Hormetic effects on the expression of genes involved in DNA replication and efflux were observed. Inhibition of biofilm formation and induction of oxidative stress were caused by 0.5, 5 and 50 nmol L-1 2,4-BPS. Fatty acyls, glycerolipids and glycerophospholipids were differentially regulated by 2,4-BPS. Glycerolipid metabolism and glycine, serine and threonine metabolism were significantly altered by 0.5 nmol L-1 2,4-BPS, compared with glycerophospholipid metabolism disturbed by 5 and 50 nmol L-1 2,4-BPS, showing concentration-dependent responses. Trend analysis of differential lipids demonstrated that there were three significant clusters, all of which were enriched in glycerophospholipid metabolism. 2,4-BPS elicited the strongest lipidomic responses at 5 nmol L-1. Our study provides evidence for 2,4-BPS-induced toxicity to E. faecalis at environmental concentrations and contributes to a comprehensive understanding of the interaction between 2,4-BPS and Gram-positive bacteria.

Asking Why Is Necessary to Address Health Disparities: A Critical Approach for Solution-Oriented Environmental Epidemiological Research

BACKGROUND

In environmental epidemiology, we use an array of tools from various, related disciplines to answer key questions about environmental exposures in relation to health outcomes. Typically, we ask questions related to what, who, where, when, and how. We value these questions because they contribute to novel scientific discovery and our understanding of disease etiology linked to environmental exposures. In addition, these questions help us better understand who might be at highest risk of exposure and subsequent risk of disease. Although necessary for the goals of environmental epidemiology, these questions are insufficient for addressing environmental health disparities. Specifically, these questions may be able to help us describe exposure-health outcome associations but are limited in their ability to move beyond identification to intervening on observed disparities to achieve environmental health equity.

OBJECTIVES

We sought to emphasize the need to value and routinely add the key question of "Why?" in environmental epidemiological studies. In asking this additional critical question, we can identify and incorporate the structural determinants and drivers of environmental exposure disparities and determine whether these factors are linked to existing and historically recalcitrant health disparities. Further, we can design effective studies that build on existing frameworks to address the fundamental causes of environmental health disparities.

DISCUSSION

This commentary underscores the need to routinely incorporate "why" questions in the practice of environmental epidemiology. By asking and addressing "Why?" we can employ better, more solution-oriented study designs, improve data collection, and enhance our ability to collaborate with diverse study populations through trust-building and community-engaged research. Incorporating these approaches will move environmental epidemiology forward from mostly documenting to actively addressing environmental health disparities. https://doi.org/10.1289/EHP14513.

Mechanisms underlying sex differences in autoimmunity

Autoimmune diseases are a leading cause of disability worldwide. Most autoimmune diseases occur more often in women than men, with rheumatic autoimmune diseases being among those most highly expressed in women. Several key factors, identified mainly in animal models and cell culture experiments, are important in increasing autoimmune disease in females. These include sex hormones, immune genes including those found on the X chromosome, sex-specific epigenetic effects on genes by estrogen and the environment, and regulation of genes and messenger RNA by microRNAs found in extracellular vesicles. Evidence is also emerging that viruses as well as drugs or toxins that damage mitochondria may contribute to increased levels of autoantibodies against nuclear and mitochondrial antigens, which are common in many autoimmune diseases. The purpose of this Review is to summarize our current understanding of mechanisms that may determine sex differences in autoimmune disease.

Insight into the Binding Interaction between PEDCs and hERRγ Utilizing Molecular Docking and Molecular Dynamics Simulations

Phenolic environmental endocrine-disrupting chemicals (PEDCs) are persistent EDCs that are widely found in food packaging materials and environmental media and seriously threaten human health and ecological security. Human estrogen-related receptor γ (hERRγ) has been proposed as a mediator for the low-dose effects of many environmental PEDCs; however, the atomic-level descriptions of dynamical structural features and interactions of hERRγ and PEDCs are still unclarified. Herein, how three PEDCs, 4-(1-methylpropyl)phenol (4-sec-butylphenol), 5,6,7,8-tetrahydro-2-naphthol (tetrahydro-2-napthol), and 2,2-bis(4-hydroxy-3,5-dimethoxyphenyl)propane (BP(2,2)(Me)), interact with hERRγ to produce its estrogenic disruption effects was studied. Molecular docking and multiple molecular dynamics (MD) simulations were first conducted to distinguish the detailed interaction pattern of hERRγ with PEDCs. These binding structures revealed that residues around Leu271, Leu309, Leu345, and Phe435 are important when binding with PEDCs. Furthermore, the binding energies of PEDCs with hERRγ were also characterized using the molecular mechanics/Poisson Boltzmann surface area (MM-PBSA) and solvated interaction energy (SIE) methods, and the results showed that the interactions of CH-π, π-π, and hydrogen bonds are the major contributors for hERRγ binding to these three PEDCs. What is striking is that the methoxide groups of BP(2,2)(Me), as hydrophobic groups, can help to reduce the binding energy of PEDCs binding with hERRγ. These results provide important guidance for further understanding the influence of PEDCs on human health problems.